American Society of Clinical Oncology technology assessment working group update: Use of aromatase inhibitors in the adjuvant setting

Eric P. Winer, Clifford Hudis, Harold J. Burstein, John Bryant, Rowan T. Chlebowski, James N. Ingle, Stephen B. Edge, Eleftherios P. Mamounas, Richard Gelber, Julie Gralow, Lori J. Goldstein, Kathleen I. Pritchard, Susan Braun, Melody A. Cobleigh, Amy S. Langer, Judy Perotti, Trevor J. Powles, Timothy J. Whelan, George P. Browman

Research output: Contribution to journalReview article

77 Scopus citations
Original languageEnglish (US)
Pages (from-to)2597-2599
Number of pages3
JournalJournal of Clinical Oncology
Volume21
Issue number13
DOIs
StatePublished - Jul 1 2003

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Winer, E. P., Hudis, C., Burstein, H. J., Bryant, J., Chlebowski, R. T., Ingle, J. N., Edge, S. B., Mamounas, E. P., Gelber, R., Gralow, J., Goldstein, L. J., Pritchard, K. I., Braun, S., Cobleigh, M. A., Langer, A. S., Perotti, J., Powles, T. J., Whelan, T. J., & Browman, G. P. (2003). American Society of Clinical Oncology technology assessment working group update: Use of aromatase inhibitors in the adjuvant setting. Journal of Clinical Oncology, 21(13), 2597-2599. https://doi.org/10.1200/JCO.2003.04.596